Patent · US Active

PGDH inhibitors and methods of making and using

US11345702B1 · kind B1 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2021
Grant dateMay 31, 2022
Priority date—
Expiry dateSep 24, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compounds that can inhibit 15-hydroxyprostaglandin dehydrogenase. Such compounds may be administered to subjects that may benefit from modulation of prostaglandin levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.